| 2018 | 14-3-3 zeta Overexpression is Associated with Poor Prognosis in Ovarian Cancer | 김승철; 성순희; 조민선; 주웅; 김윤환 | Article |
| 2026 | A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study | 김윤환 | Article |
| 2025 | CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid | 권영주 | Article |
| 2020 | Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene | 손연수; 이화정; 전용주; Prakash Gouda Avaji | Article |
| 2000 | Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer | 홍영숙 | Article |
| 2020 | Inhibition of p300 by Garcinol Protects against Cisplatin-Induced Acute Kidney Injury through Suppression of Oxidative Stress, Inflammation, and Tubular Cell Death in Mice | 조정민 | Article |
| 2020 | Kahweol Ameliorates Cisplatin-Induced Acute Kidney Injury through Pleiotropic Effects in Mice | 조정민 | Article |
| 2021 | Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial | 김승철; 주웅; 김윤환 | Article |
| 2019 | Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation | 박윤정 | Article |
| 2022 | Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury | 조정민 | Article |
